Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Sep;80(1):73–80. doi: 10.1111/j.1476-5381.1983.tb11051.x

Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis.

U Aehringhaus, B A Peskar, H R Wittenberg, R H Wölbling
PMCID: PMC2044980  PMID: 6689134

Abstract

The effects of infusions of the lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA, 1.1 X 10(-7) mol min-1) and the antagonist of slow-reacting substance of anaphylaxis (SRS-A) FPL 55712 (1.2 X 10(-7) mol min-1) on the coronary constriction and the release of SRS-A, leukotreine C4-like immunoreactivity, thromboxane B2 and 6-keto-prostaglandin F1 alpha from perfused anaphylactic guinea-pig hearts were investigated. Both NDGA and FPL 55712 in the concentrations used induced an increase in basal coronary flow, but did not prevent the coronary flow reduction in the early phase (0-4 min) after antigen injection. On the other hand, NDGA and FPL 55712 inhibited the less pronounced long-lasting coronary flow reduction in the later phase of cardiac anaphylaxis. NDGA decreased the release of SRS-A from the anaphylactic guinea-pig hearts below or close to the detection limit of the bioassay and simultaneously diminished the release of leukotriene C4-like immunoreactivity. On the other hand, FPL 55712 did not influence the amounts of leukotriene C4-like immunoreactivity released in cardiac anaphylaxis. Neither NDGA nor FPL 55712 affected the release of immunoreactive thromboxane B2 (TXB2) from anaphylactic guinea-pig hearts. Release of 6-keto-prostaglandin F1 alpha after challenge, however, was decreased by NDGA, while FPL 55712 had no significant effect. These results suggest, that SRS-A may be a relatively more important mediator in the late phase of coronary constriction occurring during cardiac anaphylaxis, while the effects of other mediators, particularly vasoconstrictor cyclo-oxygenase products, seem to prevail in the early phase.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aehringhaus U., Wölbling R. H., König W., Patrono C., Peskar B. M., Peskar B. A. Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett. 1982 Sep 6;146(1):111–114. doi: 10.1016/0014-5793(82)80715-1. [DOI] [PubMed] [Google Scholar]
  2. Allan G., Levi R. Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro. J Pharmacol Exp Ther. 1981 Apr;217(1):157–161. [PubMed] [Google Scholar]
  3. Anhut H., Bernauer W., Peskar B. A. Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis. Prostaglandins. 1978 May;15(5):889–900. doi: 10.1016/0090-6980(78)90156-9. [DOI] [PubMed] [Google Scholar]
  4. Anhut H., Bernauer W., Peskar B. A. Radioimmunological determination of thromboxane release in cardiac anaphylaxis. Eur J Pharmacol. 1977 Jul 1;44(1):85–88. doi: 10.1016/0014-2999(77)90120-0. [DOI] [PubMed] [Google Scholar]
  5. Augstein J., Farmer J. B., Lee T. B., Sheard P., Tattersall M. L. Selective inhibitor of slow reacting substance of anaphylaxis. Nat New Biol. 1973 Oct 17;245(146):215–217. doi: 10.1038/newbio245215a0. [DOI] [PubMed] [Google Scholar]
  6. BROCKLEHURST W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960 Jun;151:416–435. doi: 10.1113/jphysiol.1960.sp006449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burke J. A., Levi R., Guo Z. G., Corey E. J. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther. 1982 Apr;221(1):235–241. [PubMed] [Google Scholar]
  8. CHAKRAVARTY N. The mechanism of histamine release in anaphylactic reaction in guinea pig and rat. Acta Physiol Scand. 1960 Mar 18;48:146–166. doi: 10.1111/j.1748-1716.1960.tb01854.x. [DOI] [PubMed] [Google Scholar]
  9. CHAKRAVARTY N. The occurrence of a lipid-soluble smooth-muscle stimulating principle ('SRS') in anaphylactic reaction. Acta Physiol Scand. 1960 Mar 18;48:167–177. doi: 10.1111/j.1748-1716.1960.tb01855.x. [DOI] [PubMed] [Google Scholar]
  10. Engineer D. M., Morris H. R., Piper P. J., Sirois P. The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition. Br J Pharmacol. 1978 Oct;64(2):211–218. doi: 10.1111/j.1476-5381.1978.tb17291.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FEIGEN G. A., VAUGHAN WILLIAMS E. M., PETERSON J. K., NIELSEN C. B. Histamine release and intracellular potentials during anaphylaxis in the isolated heart. Circ Res. 1960 Jul;8:713–723. doi: 10.1161/01.res.8.4.713. [DOI] [PubMed] [Google Scholar]
  12. Giotti A., Guidotti A., Mannaioni P. F., Zilletti L. The influences of andrenotropic drugs and noradrenaline on the histamine release in cardiac anaphylaxis in vitro. J Physiol. 1966 Jun;184(4):924–941. doi: 10.1113/jphysiol.1966.sp007957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamberg M. On the formation of thromboxane B2 and 12l-hydroxy-5,8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pig. Biochim Biophys Acta. 1976 Jun 22;431(3):651–654. doi: 10.1016/0005-2760(76)90232-0. [DOI] [PubMed] [Google Scholar]
  14. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979 Jun 15;28(12):1959–1961. doi: 10.1016/0006-2952(79)90651-8. [DOI] [PubMed] [Google Scholar]
  15. Krell R. D., Osborn R., Falcone K., Vickery L. Enhancement of isolated airway responses to bronchoconstrictive agonists by the slow-reacting substance of anaphylaxis antagonist FPL 55712. Prostaglandins. 1981 Sep;22(3):423–432. doi: 10.1016/0090-6980(81)90103-9. [DOI] [PubMed] [Google Scholar]
  16. Letts L. G., Piper P. J. The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br J Pharmacol. 1982 May;76(1):169–176. doi: 10.1111/j.1476-5381.1982.tb09203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levi R., Allan G., Zavecz J. H. Prostaglandins and cardiac anaphylaxis. Life Sci. 1976 Jun 1;18(11):1255–1264. doi: 10.1016/0024-3205(76)90202-2. [DOI] [PubMed] [Google Scholar]
  18. Levi R. Effects of exogenous and immunologically released histamine on the isolated heart: a quantitative comparison. J Pharmacol Exp Ther. 1972 Aug;182(2):227–238. [PubMed] [Google Scholar]
  19. Liebig R., Bernauer W., Peskar B. A. Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(1):65–76. doi: 10.1007/BF00498030. [DOI] [PubMed] [Google Scholar]
  20. MONGAR J. L., SCHILD H. O. A comparison of the effects of anaphylactic shock and of chemical histamine releasers. J Physiol. 1952 Dec;118(4):461–478. doi: 10.1113/jphysiol.1952.sp004808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Michelassi F., Landa L., Hill R. D., Lowenstein E., Watkins W. D., Petkau A. J., Zapol W. M. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science. 1982 Aug 27;217(4562):841–843. doi: 10.1126/science.6808665. [DOI] [PubMed] [Google Scholar]
  22. Morris H. R., Piper P. J., Taylor G. W., Tippins J. R. The role of arachidonate lipoxygenase in the release of SRS-A from guinea-pig chopped lung. Prostaglandins. 1980 Mar;19(3):371–383. doi: 10.1016/0090-6980(80)90071-4. [DOI] [PubMed] [Google Scholar]
  23. Morris H. R., Taylor G. W., Piper P. J., Tippins J. R. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature. 1980 May 8;285(5760):104–106. doi: 10.1038/285104a0. [DOI] [PubMed] [Google Scholar]
  24. Murphy R. C., Hammarström S., Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4275–4279. doi: 10.1073/pnas.76.9.4275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Samuelsson B., Borgeat P., Hammarström S., Murphy R. C. Leukotrienes: a new group of biologically active compounds. Adv Prostaglandin Thromboxane Res. 1980;6:1–18. [PubMed] [Google Scholar]
  26. Schild H. O. Histamine release in anaphylactic shock from various tissues of the guinea-pig. J Physiol. 1939 Apr 14;95(3):393–403. doi: 10.1113/jphysiol.1939.sp003736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. TAPPEL A. L., LUNDBERG W. O., BOYER P. D. Effect of temperature and antioxidants upon the lipoxidase-catalyzed oxidation of sodium linoleate. Arch Biochem Biophys. 1953 Feb;42(2):293–304. doi: 10.1016/0003-9861(53)90359-2. [DOI] [PubMed] [Google Scholar]
  28. Welton A. F., Hope W. C., Tobias L. D., Hamilton J. G. Inhibition of antigen-induced histamine release and thromboxane synthase by FPL 55712, a specific SRA-A antagonist? Biochem Pharmacol. 1981 Jun 1;30(11):1378–1382. doi: 10.1016/0006-2952(81)90328-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES